Effect of intracameral XXXX on postoperative intraocular inflammation in pediatric traumatic @entity231 .

@entity1 @entity32 @entity2995 @entity227 @entity231 @entity5862 @entity3225 @entity2713
PURPOSE: To study the effect of a single intracameral injection of @entity2995 at the end of pediatric traumatic @entity231 surgery on postoperative @entity32 . METHODS: This prospective interventional study comprised 40 eyes of @entity1 with unilateral traumatic @entity231 . @entity1 were classified into 2 groups: the study group, in which intraoperative intracameral @entity2995 (2 mg) was used at the end of surgery; and a control group, which did not receive intracameral @entity2995 . RESULTS: The study group included 20 eyes of @entity1 with an average age of 6    2.8 years. The control group included 20 eyes of @entity1 with an average age of 6    2.1 years. No serious intraoperative complications occurred. In the immediate postoperative period, 3 eyes of the control group (15.0%) developed a fibrinous anterior chamber reaction. None of the study group eyes developed a similar reaction. There were no cases of @entity3225 . In addition, 3 eyes (15%) in the control group had obscuration of the @entity227 at the last follow-up. This complication was not encountered in the study group. @entity5862 and cellular deposits were observed in 4 eyes (20%) in the study group and 8 eyes (40%) in the control group at 1 month and at the last follow-up. CONCLUSIONS: The use of intracameral @entity2713 decreased anterior segment @entity32 postoperatively in @entity1 who had surgery for traumatic @entity231 .
